Bausch Health Companies Inc (BHC : TSX)
Common Stock
$7.31
CAD
+0.41 (5.94%)
Last updated: 2026-06-04
BHC
Bausch Health Companies Inc
WealthAwesomePerformance
1 Day
+5.94%
1 Week
-2.27%
1 Month
-5.06%
YTD
-26.31%
Key Statistics
Market Cap
$2.80B
52W High
$11.97
52W Low
$6.53
P/E Ratio
-
50 Day MA
$7.53
200 Day MA
$8.64
Beta
0.41
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/4/2026 | $6.98 | $7.35 | $6.97 | $7.31 | $7.31 | 744,164 |
| 6/3/2026 | $6.95 | $6.97 | $6.87 | $6.90 | $6.90 | 536,433 |
| 6/2/2026 | $7.36 | $7.37 | $6.91 | $6.97 | $6.97 | 1,014,702 |
| 6/1/2026 | $7.38 | $7.52 | $7.23 | $7.36 | $7.36 | 524,779 |
| 5/29/2026 | $7.48 | $7.48 | $7.29 | $7.41 | $7.41 | 911,930 |
| 5/28/2026 | $7.45 | $7.53 | $7.37 | $7.48 | $7.48 | 299,887 |
| 5/27/2026 | $7.49 | $7.75 | $7.44 | $7.45 | $7.45 | 414,405 |
| 5/26/2026 | $7.67 | $7.72 | $7.36 | $7.46 | $7.46 | 417,364 |
| 5/25/2026 | $7.54 | $7.72 | $7.54 | $7.72 | $7.72 | 109,688 |
| 5/22/2026 | $7.52 | $7.69 | $7.43 | $7.55 | $7.55 | 337,113 |
Analyst Price Targets
Based on analyst covering BHC
Wall Street analysts forecast BHC stock price to fall 4.1% over the next 12 months.
Consensus
No RatingAvg. Target
C$7.01
-4.1% Upside
Current Price
C$7.31
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BHC's historical volatility
30-Day Vol
41.6%
Annualized
90-Day Vol
39.6%
Annualized
Trend (90d)
-1.1%
Annualized drift
90d Mean
C$7.28
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$7.30 | C$6.32 – C$8.43 |
| 60 trading days | C$7.29 | C$5.95 – C$8.93 |
| 90 trading days | C$7.28 | C$5.68 – C$9.34 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Bausch Health Companies Inc
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
Financials
- Revenue (TTM)
- $10.53B
- EBITDA
- $3.61B
- Profit Margin
- -11.47%
- ROE (TTM)
- 43.64%
- EPS (Diluted)
- -4.50
- Book Value
- -7.61
Classification
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About BHC
Articles Featuring BHC.TO
Latest articles and analysis covering BHC.TO
Bausch Health Companies Inc. (BHC.TO) Rises 5% in Last Session — What’s Driving the Momentum?
Bausch Health Companies Inc. (BHC.TO) gained 5% in the last session, driven by anticipation for its upcoming Q1 2026 results. Investors are optimistic about the company's growth potential.
Bausch Health Companies Inc. (BHC.TO) Gains Ground with a Strong Day of Trading
Bausch Health Companies Inc. saw a notable stock increase in the last session, signaling renewed investor interest amid ongoing financial challenges.
11 Best Value Stocks In Canada For June 2026
Most investors are fascinated with stories of people like Michal Burry, the man who predicted the housing market collapse of 2008 and made US $800 million by shorting the housing market. It’s a powerful example of how a unique perspective, an acute perception, and ingenious investment techniques can
![11 Best Value Stocks In Canada For [currentmonthyearfull]](https://lhajohzwizrsjmumhpjg.supabase.co/storage/v1/object/public/wealth-awesome/site-media/best-value-stocks-in-canada_4-8.jpg)